125 related articles for article (PubMed ID: 31146172)
1. Liquid chromatography-tandem mass spectrometric assay for the quantification of galunisertib in human plasma and the application in a pre-clinical study.
Tibben MM; Huijberts S; Li W; Schinkel AH; Gebretensae A; Rosing H; Beijnen JH
J Pharm Biomed Anal; 2019 Sep; 173():169-175. PubMed ID: 31146172
[TBL] [Abstract][Full Text] [Related]
2. Bioanalytical assay for the new-generation ROS1/TRK/ALK inhibitor repotrectinib in mouse plasma and tissue homogenate using liquid chromatography-tandem mass spectrometry.
Li W; Perpinioti N; Schinkel AH; Beijnen JH; Sparidans RW
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May; 1144():122098. PubMed ID: 32278292
[TBL] [Abstract][Full Text] [Related]
3. Quantitative bioanalytical assay for the tropomyosin receptor kinase inhibitor larotrectinib in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.
Sparidans RW; Wang Y; Schinkel AH; Schellens JHM; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Dec; 1102-1103():167-172. PubMed ID: 30396050
[TBL] [Abstract][Full Text] [Related]
4. Liquid chromatography-tandem mass spectrometry assay to quantify plitidepsin in human plasma, whole blood and urine.
van Andel L; Rosing H; Fudio S; Avilés P; Tibben MM; Gebretensae A; Schellens JHM; Beijnen JH
J Pharm Biomed Anal; 2017 Oct; 145():137-143. PubMed ID: 28662481
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of an LC-MS/MS method with a broad linear dynamic range for the quantification of tivozanib in human and mouse plasma, mouse tissue homogenates, and culture medium.
Bruin MAC; Rosing H; Lucas L; Wang J; Huitema ADR; Schinkel AH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep; 1125():121723. PubMed ID: 31352204
[TBL] [Abstract][Full Text] [Related]
6. A selective and robust UPLC-MS/MS method for the simultaneous quantitative determination of anlotinib, ceritinib and ibrutinib in rat plasma and its application to a pharmacokinetic study.
Du P; Guan Y; An Z; Li P; Liu L
Analyst; 2019 Sep; 144(18):5462-5471. PubMed ID: 31380858
[TBL] [Abstract][Full Text] [Related]
7. Liquid chromatography-tandem mass spectrometric assay for the ALK inhibitor crizotinib in mouse plasma.
Sparidans RW; Tang SC; Nguyen LN; Schinkel AH; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 905():150-4. PubMed ID: 22940474
[TBL] [Abstract][Full Text] [Related]
8. Liquid chromatography-tandem mass spectrometric assay for the cyclin-dependent kinase inhibitor AT7519 in mouse plasma.
Dolman ME; den Hartog IJ; Molenaar JJ; Schellens JH; Beijnen JH; Sparidans RW
J Pharm Biomed Anal; 2014 Jan; 88():216-20. PubMed ID: 24080524
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of LC-MS/MS assays for the quantification of E7080 and metabolites in various human biological matrices.
Dubbelman AC; Rosing H; Thijssen B; Gebretensae A; Lucas L; Chen H; Shumaker R; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():25-34. PubMed ID: 22309776
[TBL] [Abstract][Full Text] [Related]
10. Liquid chromatography-tandem mass spectrometric assay for the PI3K/mTOR inhibitor GSK2126458 in mouse plasma and tumor homogenate.
Dolman ME; Westerhout EM; Hamdi M; Schellens JH; Beijnen JH; Sparidans RW
J Pharm Biomed Anal; 2015 Mar; 107():403-8. PubMed ID: 25659532
[TBL] [Abstract][Full Text] [Related]
11. Liquid chromatography-tandem mass spectrometric assay for the JAK2 inhibitor CYT387 in plasma.
Sparidans RW; Durmus S; Xu N; Schinkel AH; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():174-7. PubMed ID: 22476054
[TBL] [Abstract][Full Text] [Related]
12. LC-MS/MS assay for the quantitation of the tyrosine kinase inhibitor neratinib in human plasma.
Kiesel BF; Parise RA; Wong A; Keyvanjah K; Jacobs S; Beumer JH
J Pharm Biomed Anal; 2017 Feb; 134():130-136. PubMed ID: 27907855
[TBL] [Abstract][Full Text] [Related]
13. Bioanalytical method development, validation and quantification of dorsomorphin in rat plasma by LC-MS/MS.
Karthikeyan K; Mahat MY; Chandrasekaran S; Gopal K; Franklin PX; Sivakumar BJ; Singh G; Narayanan S; Gopalan B; Khan AA
Biomed Chromatogr; 2013 Aug; 27(8):1018-26. PubMed ID: 23526253
[TBL] [Abstract][Full Text] [Related]
14. A rapid and sensitive LC-MS/MS method for evaluation of the absolute oral bioavailability of a novel c-Met tyrosine kinase inhibitor QBH-196 in rats.
Zhang Q; Sun J; Lu T; Zhang J; Wu C; Li L; He Z; Zhao Y; Liu X
Biomed Chromatogr; 2015 Nov; 29(11):1650-6. PubMed ID: 25880630
[TBL] [Abstract][Full Text] [Related]
15. Bioanalysis in clinical development of tasquinimod using liquid chromatography/tandem mass spectrometry.
Hansson GP; Olin M; Svanström C; Svensson LD; Sennbro CJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3401-6. PubMed ID: 21963277
[TBL] [Abstract][Full Text] [Related]
16. Liquid chromatography-tandem mass spectrometric assay for the mutated BRAF inhibitor vemurafenib in human and mouse plasma.
Sparidans RW; Durmus S; Schinkel AH; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 889-890():144-7. PubMed ID: 22386128
[TBL] [Abstract][Full Text] [Related]
17. Liquid chromatography-tandem mass spectrometry assay for the quantification of niraparib and its metabolite M1 in human plasma and urine.
van Andel L; Zhang Z; Lu S; Kansra V; Agarwal S; Hughes L; Tibben MM; Gebretensae A; Rosing H; Schellens JHM; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():14-21. PubMed ID: 27898364
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of an LC-MS/MS method for the determination of a novel thienoquinolin urea transporter inhibitor PU-48 in rat plasma and its application to a pharmacokinetic study.
Zhang ZY; Wang X; Liu D; Zhang H; Zhang Q; Lu YY; Li P; Lou YQ; Yang BX; Lu C; Lou YX; Zhang GL
Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29193233
[TBL] [Abstract][Full Text] [Related]
19. Quantification and pharmacokinetics of crizotinib in rats by liquid chromatography-tandem mass spectrometry.
Qiu F; Gu Y; Wang T; Gao Y; Li X; Gao X; Cheng S
Biomed Chromatogr; 2016 Jun; 30(6):962-8. PubMed ID: 26467669
[TBL] [Abstract][Full Text] [Related]
20. Sensitive and rapid liquid chromatography/tandem mass spectrometric assay for the quantification of piperaquine in human plasma.
Singhal P; Gaur A; Gautam A; Varshney B; Paliwal J; Batra V
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(1):24-9. PubMed ID: 17923446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
